Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines,
The Senior Medical Director, Oncology Clinical Development - GU will report to the Executive Medical Director, Clinical Development Lead (CDL), Oncology Clinical Development. The Sr. Medical Director will be responsible for clinical research activities pertaining to
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our
The Director, Global Content Design and Delivery, Oncology in the Global Scientific Communications organization is responsible for chairing Global Integrated Medical Communication Teams (GIMCT) for a Oncology asset/disease area and driving the development of Integrated Medical Communication
Data & Predictive Sciences will only be successful by working in close collaboration with Research Technologies, Therapy Areas, GSK Tech, AIML, Vaccines, Risk &Compliance, and across lines within the functionitself, and by developing and fostering a
Data & Predictive Sciences will only be successful by working in close collaboration with Research Technologies, Therapy Areas, GSK Tech, AIML, Vaccines, Risk &Compliance, and across lines within the functionitself, and by developing and fostering a
Acadia Pharmaceuticals is a company dedicated to innovation in neurological and rare disease therapies. Our portfolio includes the first FDA‑approved treatments for Parkinson’s disease psychosis and Rett syndrome, and we are developing additional programs in Alzheimer’s
The Senior Medical Director, Oncology Clinical Development - GU will report to the Executive Medical Director, Clinical Development Lead (CDL), Oncology Clinical Development. The Sr. Medical Director will be responsible for clinical research activities pertaining to
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our